Clinicopathological characteristics and expression of ER, PR, HER2, HIF-1α, CAIX and Glut-1 in DCIS and accompanying invasive lesions of BRCA1, BRCA2 and non-BRCA mutation carriers. This evidence concerns the gene BRCA2 and ductal breast carcinoma in situ.